Chemically injured keratocytes induce cytokine release by human peripheral mononuclear cells

Cytokine

Volumn 59, Issue 2, 2012, Pages 280-285

  Jeon, Hyun Sun ^a   Yi, Kayoung ^a   Chung, Tae Young ^b   Hyon, Joon Young ^c   Wee, Won Ryang ^c   Shin, Young Joo ^a  

^a Hallym University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Human peripheral blood mononuclear cells; Keratocyte; Macrophage migration inhibitory factor; Matrix metalloprotease 9; Transforming growth factor beta 1

Indexed keywords

GELATINASE B; MACROPHAGE MIGRATION INHIBITION FACTOR; SODIUM HYDROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CHEMICAL BURN; CONTROLLED STUDY; CORNEA BURN; CORNEA EPITHELIUM; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATINOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

CELLS, CULTURED; CORNEAL KERATOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MATRIX METALLOPROTEINASE 9; MICROSCOPY, PHASE-CONTRAST; SODIUM HYDROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84862335333     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.006     Document Type: Article

References (37)

1. Wagoner M.D. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997, 41:275-313.
2. Tseng S.C.G. Concept and applications of limbal stem cells. Eye 1989, 3:141-157.
3. Dohlman C.H., Cade F., Pfister R. Chemical burns to the eye: paradigm shifts in treatment. Cornea 2011, 3D:613-614.
4. Nirankari V.S. Superoxide radical scavenging agents in treatment of alkali burns. Arch Ophthalmol 1981, 99:886.
5. Ormerod L.D., Garsd A., Abelson M.B., Kenyon K.R. Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali burned rabbit cornea. Am J Pathol 1990, 137:1243-1252.
6. Fish R., Davidson R.S. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol 2010, 21:317-321.
7. Saito T., Nishida K., Sugiyama H., Yamato M., Maeda N., Okano T., et al. Abnormal keratocytes and stromal inflammation in chronic phase of severe ocular surface diseases with stem cell deficiency. Br J Ophthalmol 2008, 92:404-410.
8. Dua H.S., Azuara-Blanco A. Limbal stem cells of the corneal epithelium. Surv Ophthalmol 2000, 44:415-425.
9. Fujisawa K., Katakami C., Yamamoto M. Keratocyte activity during wound healing of alkali-burned cornea. Nippon Ganka Gakkai Zasshi 1991, 95:59-66.
10. Park W.C., Tseng S.C. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci 2000, 41:2906-2914.
11. Chakravarti S., Wu F., Vij N., Roberts L., Joyce S. Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea. Invest Ophthalmol Vis Sci 2004, 45:3475-3484.
12. Sotozono C., He J., Matsumoto Y., Kita M., Imanishi J., Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997, 16:670-676.
13. Matsubara M., Zieske J.D., Fini M.E. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991, 32:3221-3237.
14. Brejchova K., Liskova P., Hrdlickova E., Filipec M., Jirsova K. Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome. Mol Vis 2009, 15:2364-2372.
15. Mohan R.R., Hutcheon A.E., Choi R., Hong J., Lee J., Mohan R.R., et al. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res 2003, 76:71-87.
16. Oh S.Y., Choi J.S., Kim E.J., Chuck R.S., Park C.Y. The role of macrophage migration inhibitory factor in ocular surface disease pathogenesis after chemical burn in the murine eye. Mol Vis 2010, 16:2402-2411.
17. Bourcier T., Borderie V., Forgez P., Lombet A., Rostène W., Laroche L. In vitro effect of dexamethasone on human corneal keratocytes. Invest Ophthalmol Vis Sci 1999, 40:1061-1070.
18. Borderie V.M., Lopez M., Lombet A., Carvajal-Gonzalez S., Cywiner C., Laroche L. Cryopreservation and culture of human corneal keratocytes. Invest Ophthalmol Vis Sci 1998, 39:1511-1519.
19. Musselmann K., Kane B.P., Hassell J.R. Isolation of a putative keratocyte activating factor from the corneal stroma. Exp Eye Res 2003, 77:273-279.
20. Koizumi N., Fullwood N., Bairaaktaris G., Inatomi T., Kinoshita S., Quantock A. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 2000, 41:2506-2513.
21. Geerling G., Daniels J.T., Dart J.K.G., Cree I.A., Khaw P.T. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 2001, 42:948-956.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
23. Pathak S., Goldofsky E., Vivas E.X., Bonagura V.R., Vambutas A. IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol 2011, 186:1870-1879.
24. Yang L., Hou Y. Different characters of spleen OX-62 positive dendritic cells between Fischer and Lewis rats. Cell Mol Immunol 2006, 3:145-150.
25. Møller-Pedersen T., Cavanagh H.D., Petroll W.M., Jester J.V. Neutralizing antibody to TGF-beta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res 1998, 17:736-747.
26. Fink S.L., Cookson B.T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005, 73:1907-1916.
27. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
28. Fridman R., Toth M., Chvyrkova I., Meroueh S.O., Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003, 22:153-166.
29. Konttinen Y.T., Halinen S., Hanemaaijer R., Sorsa T., Hietanen J., Ceponis A., et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 1998, 17:335-347.
30. Ye H.Q., Azar D.T. Expression of gelatinases A and B, and TIMPS 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci 1998, 39:913-921.
31. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800.
32. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71.
33. Daun J.M., Cannon J.G. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am J Physiol Regul Integr Comp Physiol 2000, 279:R1043-9.
34. Gadjeva M., Nagashima J., Zaidi T., Mitchell R.A., Pier G.B. Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog 2010, 6:e1000826.
35. Park C.Y., Shin Y.J., Lekhanont K., Zhang C., Lee W.S., Cano M., et al. High expression of macrophage migration inhibitory factor in the murine lacrimal gland. Cornea 2010, 29:187-191.
36. Chen M., Matsuda H., Wang L., Watanabe T., Kimura M.T., Igarashi J., et al. Pretranscriptional regulation of Tgf-beta1 by PI polyamide prevents scarring and accelerates wound healing of the cornea after exposure to alkali. Mol Ther 2010, 18:519-527.
37. Xing D., Bonanno J.A. Hypoxia reduces TGF-beta1-induced corneal keratocyte myofibroblast transformation. Mol Vis 2009, 15:1827-1834.